About Joel Kaufman
Joel Kaufman is an executive officer at Baylor Genetics.
Form D filings also name Joel Kaufman as an executive officer at PrognomIQ.
Experience
This experience comes from Joel Kaufman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joel Kaufman in the role, so the role may have started earlier or lasted longer.
Baylor Genetics Holdings, Inc.
Chief Financial Officer
2026 · Houston, TX
Provides genetic testing and diagnostic services for healthcare providers and patients.
HO
Haystack Oncology
Chief Financial Officer
2022 – 2025
SE
Sema4
Vice President of Finance & Corporate Development
2021 – 2022
NB
Navidea Biopharmaceuticals
Chief Business Officer
2017 – 2021
GS
Goldman Sachs
Equity Research Associate - Medical Technology
2010 – 2017
Key Colleagues at Startups
The people Joel Kaufman works with at each company, as listed on that company's latest Form D.
Baylor Genetics Holdings, Inc. · Form D, Jul 16, 2026
BL
Brendan Lee
Scientific Advisory Board Chair
XC
Xiangmin Cui
Director
GI
Goki Ishikawa
Director
Kengo Takishima
Chairman, Chief Executive Officer
VT
Victor Tong
Director
DB
David Berger
Chief Legal Officer and Secretary
PrognomIQ, Inc. · Form D, Aug 11, 2025
RD
Rajesh Garg, M.D.
Director
MD
Mark McClellan, M.D., Ph.D.
Director
PD
Philip Ma, Ph.D.
Chief Executive Officer and director
BD
Bruce Wilcox, Ph.D.
Executive officer
OD
Omid Farokhzad, M.D.
Director
ID
Isaac Ro, Ph.D.
Director
TD
Tomer Berkovitz, Ph.D.
Director
BD
Brian Koh, M.D.
Executive officer